MicroRNA-34a upregulation during seizure-induced neuronal death

Cell Death and Disease

Volumn 3, Issue 3, 2012, Pages

  Sano, T ^a,b   Reynolds, J P ^a   Jimenez Mateos, E M ^a   Matsushima, S ^b   Taki, W ^b   Henshall, D C ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dicer; Epileptogenesis; Hippocampal sclerosis; p53; Temporal lobe epilepsy

Indexed keywords

ARGONAUTE 2 PROTEIN; MICRORNA; MICRORNA 34A; MITOGEN ACTIVATED PROTEIN KINASE 9; PIFITHRIN ALPHA; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; EPILEPTIC STATE; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; HUMAN; IMMUNOPRECIPITATION; MALE; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; APOPTOSIS; ARGONAUTE PROTEINS; BENZOTHIAZOLES; HIPPOCAMPUS; IMMUNOPRECIPITATION; KAINIC ACID; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; PROTEIN BINDING; SEIZURES; TOLUENE; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

MUS;

EID: 84859361521     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2012.23     Document Type: Article

References (40)

1. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
2. Kim VN, Han J, Siomi MC. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 2009; 10: 126-139.
3. Peters L, Meister G. Argonaute proteins: mediators of RNA silencing. Mol Cell 2007; 26: 611-623. (Pubitemid 46856239)
4. Eacker SM, Dawson TM, Dawson VL. Understanding microRNAs in neurodegeneration. Nat Rev Neurosci 2009; 10: 837-841.
5. Aronica E, Fluiter K, Iyer A, Zurolo E, Vreijling J, van Vliet EA et al. Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy. Eur J Neurosci 2010; 31: 1100-1107.
6. Hu K, Zhang C, Long L, Long X, Feng L, Li Y et al. Expression profile of microRNAs in rat hippocampus following lithium-pilocarpine-induced status epilepticus. Neurosci Lett 2011; 488: 252-257.
7. Jimenez-Mateos EM, Bray I, Sanz-Rodriguez A, Engel T, McKiernan R, Mouri G et al. MicroRNA expression profile after status epilepticus and hippocampal neuroprotection by targeting miR-132. Am J Pathol 2011; 179: 2519-2532.
8. Riley T, Sontag E, Chen P, Levine A. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 2008; 9: 402-412. (Pubitemid 351574202)
9. Sakhi S, Bruce A, Sun N, Tocco G, Baudry M, Schreiber SS. p53 induction is associated with neuronal damage in the central nervous system. Proc Natl Acad Sci USA 1994; 91: 7525-7529. (Pubitemid 24238217)
10. Liu W, Rong Y, Baudry M, Schreiber SS. Status epilepticus induces p53 sequence-specific DNA binding in mature rat brain. Brain Res Mol Brain Res 1999; 63: 248-253. (Pubitemid 29036975)
11. Engel T, Murphy BM, Hatazaki S, Jimenez-Mateos EM, Concannon CG, Woods I et al. Reduced hippocampal damage and epileptic seizures after status epilepticus in mice lacking proapoptotic Puma. FASEB J 2010; 24: 853-861.
12. Morrison RS, Wenzel HJ, Kinoshita Y, Robbins CA, Donehower LA, Schwartzkroin PA. Loss of the p53 tumor suppressor gene protects neurons from kainate- induced cell death. J Neurosci 1996; 16: 1337-1345.
13. Culmsee C, Zhu X, Yu QS, Chan SL, Camandola S, Guo Z et al. A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid beta-peptide. J Neurochem 2001; 77: 220-228. (Pubitemid 32245096)
14. Engel T, Hatazaki S, Tanaka K, Prehn JH, Henshall DC. Deletion of puma protects hippocampal neurons in a model of severe status epilepticus. Neuroscience 2010; 168: 443-450.
15. Engel T, Tanaka K, Jimenez-Mateos EM, Caballero-Caballero A, Prehn JH, Henshall DC. Loss of p53 results in protracted electrographic seizures and development of an aggravated epileptic phenotype following status epilepticus. Cell Death Dis 2010; 1: e79.
16. Schauwecker PE, Steward O. Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targeting approaches. Proc Natl Acad Sci USA 1997; 94: 4103-4108. (Pubitemid 27180506)
17. Hermeking H. The miR-34 family in cancer and apoptosis. Cell Death Differ 2010; 17: 193-199.
18. Welch C, Chen Y, Stallings RL. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 2007; 26: 5017-5022. (Pubitemid 47172643)
19. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 2007; 26: 731-743. (Pubitemid 46856247)
20. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 2007; 26: 745-752. (Pubitemid 46856245)
21. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y et al. A microRNA component of the p53 tumour suppressor network. Nature 2007; 447: 1130-1134. (Pubitemid 47014436)
22. Tarasov V, Jung P, Verdoodt B, Lodygin D, Epanchintsev A, Menssen A et al. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 2007; 6: 1586-1593. (Pubitemid 47327945)
23. Agostini M, Tucci P, Steinert JR, Shalom-Feuerstein R, Rouleau M, Aberdam D et al. microRNA-34a regulates neurite outgrowth, spinal morphology, and function. Proc Natl Acad Sci USA 2011; 108: 21099-21104.
24. Choi YJ, Lin CP, Ho JJ, He X, Okada N, Bu P et al. miR-34 miRNAs provide a barrier for somatic cell reprogramming. Nat Cell Biol 2011; 13: 1353-1360.
25. Tivnan A, Tracey L, Buckley PG, Alcock LC, Davidoff AM, Stallings RL. MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma. BMC Cancer 2011; 11: 33.
26. Kaller M, Liffers ST, Oeljeklaus S, Kuhlmann K, Roh S, Hoffmann R et al. Genome-wide characterization of miR-34a induced changes in protein and mRNA expression by a combined pulsed SILAC and microarray analysis. Mol Cell Proteomics 2011; 10: M111. 010462.
27. Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV et al. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 1999; 285: 1733-1737. (Pubitemid 29428873)
28. Wood DE, Newcomb EW. Cleavage of Bax enhances its cell death function. Exp Cell Res 2000; 256: 375-382. (Pubitemid 30244196)
29. Song YJ, Tian XB, Zhang S, Zhang YX, Li X, Li D et al. Temporal lobe epilepsy induces differential expression of hippocampal miRNAs including let-7e and miR-23a/b. Brain Res 2011; 1387: 134-140.
30. Saugstad JA. MicroRNAs as effectors of brain function with roles in ischemia and injury, neuroprotection, and neurodegeneration. J Cereb Blood Flow Metab 2010; 30: 1564-1576.
31. Mouri G, Jimenez-Mateos E, Engel T, Dunleavy M, Hatazaki S, Paucard A et al. Unilateral hippocampal CA3-predominant damage and short latency epileptogenesis after intra-amygdala microinjection of kainic acid in mice. Brain Res 2008; 1213: 140-151.
32. Murphy B, Dunleavy M, Shinoda S, Schindler C, Meller R, Bellver-Estelles C et al. Bcl-w protects hippocampus during experimental status epilepticus. Am J Pathol 2007; 171: 1258-1268. (Pubitemid 47582899)
33. Haramati S, Navon I, Issler O, Ezra-Nevo G, Gil S, Zwang R et al. microRNA as repressors of stress-induced anxiety: the case of amygdalar miR-34. J Neurosci 2011; 31: 14191-14203.
34. Green DR, Kroemer G. Cytoplasmic functions of the tumour suppressor p53. Nature 2009; 458: 1127-1130.
35. Engel T, Murphy BM, Schindler CK, Henshall DC. Elevated p53 and lower MDM2 expression in hippocampus from patients with intractable temporal lobe epilepsy. Epilepsy Res 2007; 77: 151-156. (Pubitemid 350137687)
36. Xu S, Pang Q, Liu Y, Shang W, Zhai G, Ge M. Neuronal apoptosis in the resected sclerotic hippocampus in patients with mesial temporal lobe epilepsy. J Clin Neurosci 2007; 14: 835-840. (Pubitemid 47095337)
37. Sohn D, Graupner V, Neise D, Essmann F, Schulze-Osthoff K, Janicke RU. Pifithrin-alpha protects against DNA damage-induced apoptosis downstream of mitochondria independent of p53. Cell Death Differ 2009; 16: 869-878.
38. Christoffersen NR, Shalgi R, Frankel LB, Leucci E, Lees M, Klausen M et al. p53- independent upregulation of miR-34a during oncogene-induced senescence represses MYC. Cell Death Differ 2010; 17: 236-245.
39. Agostini M, Tucci P, Killick R, Candi E, Sayan BS, Rivetti di Val Cervo P et al. Neuronal differentiation by TAp73 is mediated by microRNA-34a regulation of synaptic protein targets. Proc Natl Acad Sci USA 2011; 108: 21093-21098.
40. Sotillo E, Laver T, Mellert H, Schelter JM, Cleary MA, McMahon S et al. Myc overexpression brings out unexpected antiapoptotic effects of miR-34a. Oncogene 2011; 30: 2587-2594.